Allogene Therapeutics
www.allogene.comAllogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease.
For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines
Please... Read More